BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 08/11/2017

FDA Announces Guidance for Developing Drugs to Treat and Prevent Recurrent Herpes Labialis

The FDA has released a guidance document to help pharmaceutical companies develop treatments and preventions for recurrent herpes labialis, a condition that affects millions of people worldwide.

Source: Federal Register — Food and Drug AdministrationOpen original release →